Jun 10, 2021 / 02:00PM GMT
David D. Chang - Allogene Therapeutics, Inc. - Co-Founder, President, CEO & Director
Good morning. This is David Chang. I'm the Chief Executive Officer and the Director of Allogene Therapeutics. I'm very happy to welcome you to the Allogene 2021 Annual Meeting of Stockholders. As you know, we are hosting today's meeting through a virtual online platform.
In order to conduct an orderly meeting, we ask you to follow the rules of conduct, which are available on the meeting materials online. While the meeting is virtual only, stockholders of record will have the opportunity to submit questions or comment through the text box located on your screen. To ask a question online, enter your question in the box below, Ask A Question, and click Submit button. We will answer questions submitted that are germane to the proposals being voted on as and if we have time. Please submit your questions now to make sure that we have -- they are reviewed and addressed.
If you intend to vote and have not already done so, you must submit your vote online now in order for it to be counted. After we describe
Allogene Therapeutics Inc Annual Shareholders Meeting Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
